SCIENTIFIC PROGRAMME

DRAFT PROGRAMME

3 December 2021, Friday 
PRE-CONFERENCE WORKSHOP

08:00 – 10:00

Radiological Assesment in Gastrointestinal Cancer
Workshop for GI Oncologists
Course chairs:
TBA, TBA

08:00-08:20

  • Principles of Radiological Imaging in Gastrointestinal Oncologyof
    - TBA

08:20-08:40

  • CT Cross Sectional Imaging of Abdomen
    - TBA

08:40-08:56

  • Principles of Radiological Ablative Treatments
    TBA

08:56-09:12

  • Principles of Embolization Treatments in GI Cancers
    - TBA

09:12-09:30

  • Essentials of Radionuclide Treatment for GI Cancers 
    - TBA

09:30-09:45

  • Nuclear Imaging in Gastrointestinal Cancers 
    - TBA

09:45-10:00 Discussion

10:00 – 10:30

Session I: Opening session
Chairs
: TBA, TBA

10:00-10:30

  • Molecular Marker Driven Treatment in Colon Cancer: Where do we Stand
    - TBA
10:30 – 10:50

Session II: Nutrition for Cancer Patients: Medical Oncologist’s Perspective
Chairs:
TBA, TBA

10:30-10:50

  • Malnutrition in Cancer: From Medical Oncologists Perspective
    - TBA
10:50 – 11:40

Session III: Esophageal Cancer Management: How Should I Treat in 2021
Chairs:
TBA, TBA

10:50-11:10

  • Esophageal Cancer Management how should I treat in 2021
    - TBA

11:10-11:30

  • Emerging Systemic Treatment Options for Esophageal Cancer
    - TBA

11:30-11:40 Discussion

11:40 – 11:50Coffee Break
11:50 – 12:50

Session IV: Role of Age and Gender in the Management of Colon Cancer
Chairs:
TBA, TBA

11:50-12:10

  • Elderly Patients with Colon Cancers
    - TBA

12:10-12:30

  • Young Patients with Colon Cancers
    - TBA

12:30-12:50

  • Gender Differences in Colon Cancers
    - TBA
12:50 - 13:30

LUNCH

13:30 – 14:10

Satellite Symposium

14:10 – 14:40Session V: Experts Answering Your Questions
Chairs:
TBA, TBA, TBA
Experts: TBA, TBA, TBA
Challengers: TBA 
14:40 – 16:00

Session VI: Gastric Cancer: Towards More Individualized Approach
Chairs: TBA, TBA

14:40-15:00

  • Adjuvant/Neoadjuvant Therapy in Gastric Cancer:
    - TBA

15:00-15:20

  • Role of Radiotherapy as Adjuvant and Neoadjuvant Treatment
    - TBA

15:20-15:40

  • Advances in the Systemic Treatment of Advanced Gastric Cancer
    - TBA

15:40-15:50

  • Management of HER-2 Positive Gastric Cancer
    - TBA

15:50-16:00 Discussion

16:00 – 16:45

Session VII: Hepatocellular Tumors
Chairs: TBA, TBA

16:00-16:15

  • New Perspectives in Classification of HCC
    - TBA

16:15-16:35

  • Advances in the Systemic Treatment of Hepatocellular Cancer
    - TBA

16:35-16:45 Discussion

16:45 – 17:40

Session VIII: Biliary Tract Cancer

16:45-17:05

  • Systemic Treatment
    - TBA

17:05-17:20

  • Molecular Alterations in Bile Duct Cancer
    - TBA

17:20-17:40

  • New Agents and Strategies on the Horizon in Bile Duct Cancer
    - TBA
17:40 – 18:20

Hot Topics in mCRC: Ask the Experts
Speaker:
TBA

 

4 December 2021, Saturday  

09:00 – 09:35

Session IX: Anal Cancer
Chairs:
TBA TBA

09:00-09:20

  • Advances is the Multimodality Treatment for Localized Disease
    - TBA

09:20-09:35

  • New Systemic Treatment Options for Metastatic Disease
    - TBA
09:35 – 10:30

Session X: Management of NETs
Chairs:
TBA, TBA

09:35-09:50

  • Radionuclide Imaging and Therapy for Neuroendocrine Tumour
    - TBA

09:50-10:05

  • How to Classify and Staging NEN?
    - TBA

10:05-10:30

  • Optimal Sequencing of Treatment in Advanced GEPNETS
    - TBA
10:30 – 11:20

Session XI: Understanding the Biology of Colorectal Cancer
Chairs:
 TBA, TBA

10:30-10:50

  • Microbiota and Colon Cancer
    - TBA

10:50-11:05

  • Obesity and Colorectal Carcinogenesis
    - TBA

11:05-11:20

  • NLR and... colon cancer
    - TBA

11:20-11:30 Discussion

11:30 – 12:25

Session XII: Summary of the Year
Chairs:
 TBA, TBA

11:30-11:55

  • Update on Adjuvant Therapy in Colon Cancer
    - TBA

11:55-12:15

  • Update on the First-Line Treatment in mCRC
    - TBA

12:15-12:25 Discussion

12:25 - 13:05

Satellite Symposium

13:05 - 13:45

Lunch

13:45 – 14:25

Session XIII: Optimizing Treatment:
Chairs:
TBA, TBA

13:45-14:05

  • Role of Maintenance Therapy in Advanced CRC
    - TBA

14:05-14:25

  • Treatment Beyond Second Line: Choosing Patients
    - TBA
14:25 - 15:05

Session XIV: Localized Rectal Cancer
Chairs:
TBA, TBA

14:25-14:45

  • Individualizing Adjuvant/ Neoadjuvant Treatment for Rectal Cancer
    - TBA

14:45-15:05

  • Surgical Management of Rectal Cancer: Where Do We Stand Today
    - TBA
15:05 - 15:45Satellite Symposium
15:45 - 16:25

Session XV: Advanced Colorectal Cancer: Individualization of Treatment I
Chairs:
TBA, TBA

15:45-16:05

  • Molecular Classification of Colon Cancer: Is it Ready for Clinical Practice?
    - TBA

16:05-16:25

  • Immunoterapies in mCRC: Where do We Stand?
    - TBA
16:25 - 17:20

Session XVI: Pancreatic Cancer
Chairs: TBA, TBA

16:25-16:45

  • Adjuvant/Neoadjuvant Treatment in Resectable Pancreas Cancer?
     - TBA

16:45- 17:00

  • Increasing Role of Genetics and Molecular Alterations in the Management of Pancreatic Cancer
    - TBA

17:00-17:20

  • Advances in the Systemic Treatment of Pancreatic Cancer
    - TBA
17:20 - 18:00

Session XVIII: Update On Rare Tumors
Chairs: TBA, TBA

17:20-17:40

  • Understanding the Molecular Biology of GISTs
    - TBA

17:40-18:00

  • Update on GIST management
    - TBA
18:00 - 19:15

SessionXIX: Advanced Colorectal Cancer: A Closer Look on Individualized Treatment
Chairs:
TBA, TBA

18:00-18:15

  • Implications of ALK, ROS1, and NTRK Rearrangements in Metastatic  Colorectal Cancer
    - TBA

18:15-18:30

  • Searching for the Most Active Combination Therapy for HER-2 Positive Metastatic Colon Cancer
    - TBA

18:30-18:45

  • Targeting Wnt Signaling in Colorectal Cancer
    - TBA

18:45-19:00

  • Targeting Wnt Signaling in Colorectal Cancer
    - TBA

19:00-19:15

  • Systemic treatment of GI cancers with RET Alterations
    - TBA
19:15 - 20:00

Meet the Expert Meeting

 

5 December 2021, Sunday  

08:30 – 09:15

Session XX: Rare Gastrointestinal Tumors
Chairs:
TBA, TBA

08:30 - 08:45   

  • Gastric Lymhoma
    - TBA

08:45 – 09:00     

  • Hemangioendotelyoma
    - TBA

09:00 - 09:15    

  • Small Intestinal Cancer
    - TBA
09:15 – 09:35

Session XXI: Supportive Care in GI Cancers
Chairs:
TBA, TBA

09:15 - 09:35

  • Principles of Intensive Care in Gastrointestinal Oncology
    - TBA
09:35 - 10:10

Session XXII: Surgical Issues in GI Cancer
Chairs: TBA, TBA

09:35 - 09:55

  • Cytoreductive Surgery and Hyperthermic Intraperitoneal
    Chemotherapy for Gastrointestinal Cancers

    - TBA

09:55 - 10:10

  • Liver Transplantation for Cancer
    - TBA
10:10 - 10:30

Coffee Break

10:30 – 11:30

Session XXIII: We Can Better Understand and Treat Metastatic Colorectal Cancer
Chairs: TBA, TBA

10:30 - 10:50

  • Liver Transplantation for Cancer
    - TBA

10:50 - 11:10

  • Addressing BRAF mutant mCRC
    - TBA

11:10 - 11:30

  • Controversies on Triplet Regimens
    - TBA
11:30 – 12:30

Session XXIV: Advanced RAS Mutant Colorectal Cancer
Chairs:
TBA, TBA

11:30-11:50

  • Clinical Characteristics of RAS Mutant Colorectal Cancers
    - TBA

11:50-12:10

  • Optimal Systemic Treatment Strategies for Ras Mutant Colorectal Cancer
    - TBA

12:10-12:30

  • Emerging New Drug for Ras Mutatant Colon Cancer
    - TBA
12:30 – 13:20

Session XXV: Special Issues in the Management of GI Cancer-1
Chairs:
TBA, TBA

12:30-12:45

  • Identifying and Management of Chemotherapy Associated Hepatotoxicity
    - TBA

12:45- 13:05

  • Identifying and Management of Immune-Related Adverse Reactions
    - TBA

13:05- 13:20

  • Addressing Cardiac Toxicity in GI Cancer Patient
    - TBA
13:20 - 14:15

Session XXVI: Changing Paradigm in Colorectal Cancer
Chairs: TBA, TBA

13:20- 13:35

  • Time to move to Neoadjuvant Treatment for Colon Cancer
    - TBA

13:35- 13:55

  • Circulating Tumor DNA: Emerging Role in Adjuvant and Advanced
    Disease Therapy
    - TBA

13:55- 14:15

  • Systemic Therapy for MSI High Colon Cancer
    - TBA
14:15 - 14:30

Closing Remarks